期刊文献+

Hyperspectral autofluorescence characterization of drusen and sub-RPE deposits in age-related macular degeneration

下载PDF
导出
摘要 Background:Soft drusen and basal linear deposit(BLinD)are two forms of the same extracellular lipid rich material that together make up an Oil Spill on Bruch’s membrane(BrM).Drusen are focal and can be recognized clinically.In contrast BLinD is thin and diffusely distributed,and invisible clinically,even on highest resolution OCT,but has been detected on en face hyperspectral autofluorescence(AF)imaging ex vivo.We sought to optimize histologic hyperspectral AF imaging and image analysis for recognition of drusen and sub-RPE deposits(including BLinD and basal laminar deposit),for potential clinical application.Methods:Twenty locations specifically with drusen and 12 additional locations specifically from fovea,perifovea and mid-periphery from RPE/BrM flatmounts from 4 AMD donors underwent hyperspectral AF imaging with 4 excitation wavelengths(λex 436,450,480 and 505 nm),and the resulting image cubes were simultaneously decomposed with our published non-negative matrix factorization(NMF).Rank 4 recovery of 4 emission spectra was chosen for each excitation wavelength.Results:A composite emission spectrum,sensitive and specific for drusen and presumed sub-RPE deposits(the SDr spectrum)was recovered with peak at 510-520 nm in all tissues with drusen,with greatest amplitudes at excitationsλ_(ex)436,450 and 480 nm.The RPE spectra of combined sources Lipofuscin(LF)/Melanolipofuscin(MLF)were of comparable amplitude and consistently recapitulated the spectra S1,S2 and S3 previously reported from all tissues:tissues with drusen,foveal and extra-foveal locations.Conclusions:A clinical hyperspectral AF camera,with properly chosen excitation wavelengths in the blue range and a hyperspectral AF detector,should be capable of detecting and quantifying drusen and sub-RPE deposits,the earliest known lesions of AMD,before any other currently available imaging modality.
出处 《Annals of Eye Science》 2021年第1期20-27,共8页 眼科学年鉴(英文)
基金 NIH/NEI R01 EY027948(CC,YT,RTS,TA).
  • 相关文献

参考文献1

二级参考文献57

  • 1Luis Rodrigo.Celiac disease[J].World Journal of Gastroenterology,2006,12(41):6585-6593. 被引量:3
  • 2Parsonnet J;Friedman CD;Vandersteen DP.Helicobacter pylori infection and the risk of gastric carcinoma,1991(16).
  • 3Kudo S,Lambert R,Allen JI,Fujii H,Fujii T,Kashida H,Matsuda T,Mori M,Saito H,Shimoda T,Tanaka S,Watanabe H,Sung JJ,Feld AD,Inadomi JM,O’’Brien MJ,Lieberman DA,Ransohoff DF,Soetikno RM,Triadafilopoulos G,Zauber A,Teixeira CR,Rey JF,Jaramillo E,Rubio CA,Van.Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointestinal Endoscopy . 2008
  • 4Mandel JS,Church TR,Bond JH,et al.The effect of fecal occult blood screening on the incidence of colorectal cancer. New England Journal of Medicine, The . 2000
  • 5Kumagai Y,Inoue H,Nagai K,et al.Magnifying endoscopy,stereoscopic microscopy, and the microvascular architecture of superficial esophageal carcinoma. Endoscopy . 2002
  • 6Participants in the Paris Workshop.The Paris endoscopic classif ication of superfi cial neoplastic lesions:esophagus,stomach,and colon:November 30 to December 1,2002. Gastrointestinal Endoscopy . 2003
  • 7Kudo S,Hirota S,Nakajima T,et al.Colorectal tumours and pit pattern. Journal of Clinical Pathology . 1994
  • 8Mandel JS,Bond JH,Church TR,et al.Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. New England Journal of Medicine, The . 1993
  • 9Hardcastle JD,Chamberlain JO,Robinson MH,et al.Randomised controlled trial of faecal occult blood screening for colorectal cancer. The Lancet . 1996
  • 10Correa P.Human gastric carcinogenesis: A multistep and multifactorial process-First American Cancer Socioty Award Lecture on Cancer Epidemiology and Prevention. Cancer Research . 1992

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部